Trial · NCT06212492
Registered outcomes102
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 102
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Difference between the plasma sRAGE value at the end of the first PP session and the baseline value before PP (∆ sRAGE). | Day 1 | Our primary outcome will be the comparison of the differences in plasma sRAGE levels before and after the first PP session (∆ sRAGE), a kinetic being probably more relevant than a raw value, given the observed inter-individual variations of sRAGE at basal state. |
| Secondary | Plasma determination of IL1 before the first PP session | Day 1 | Inflammation, pulmonary epithelial and endothelial dysfunction |
| Secondary | Plasma determination of IL1 1 hour after PP initiation at the first PP session | Day 1 | Inflammation, pulmonary epithelial and endothelial dysfunction |
| Secondary | Plasma determination of IL1 at the end of the first PP session | Day 1 | Inflammation, pulmonary epithelial and endothelial dysfunction |
| Secondary | Plasma determination of IL1 4 hours after return to supine after the first PP session | Day 2 | Inflammation, pulmonary epithelial and endothelial dysfunction |
| Secondary | Plasma determination of TNFα before the first PP session | Day 1 | Inflammation, pulmonary epithelial and endothelial dysfunction |
| Secondary | Plasma determination of TNFα 1 hour after PP initiation at the first PP session | Day 1 | Inflammation, pulmonary epithelial and endothelial dysfunction |
| Secondary | Plasma determination of TNFα at the end of the first PP session | Day 1 | Inflammation, pulmonary epithelial and endothelial dysfunction |
| Secondary | Plasma determination of TNFα 4 hours after return to supine after the first PP session | Day 2 | Inflammation, pulmonary epithelial and endothelial dysfunction |
| Secondary | Plasma determination of sRAGE before the first PP session | Day 1 | Inflammation, pulmonary epithelial and endothelial dysfunction |
| Secondary | Plasma determination of sRAGE 1 hour after PP initiation at the first PP session | Day 1 | Inflammation, pulmonary epithelial and endothelial dysfunction |
| Secondary | Plasma determination of sRAGE at the end of the first PP session | Day 1 | Inflammation, pulmonary epithelial and endothelial dysfunction |
| Secondary | Plasma determination of sRAGE 4 hours after return to supine after the first PP session | Day 2 | Inflammation, pulmonary epithelial and endothelial dysfunction |
| Secondary | Plasma determination of angiopoietin 2 before the first PP session | Day 1 | Inflammation, pulmonary epithelial and endothelial dysfunction |
| Secondary | Plasma determination of angiopoietin 2 1 hour after PP initiation at the first PP session | Day 1 | Inflammation, pulmonary epithelial and endothelial dysfunction |
| Secondary | Plasma determination of angiopoietin 2 at the end of the first PP session | Day 1 | Inflammation, pulmonary epithelial and endothelial dysfunction |
| Secondary | Plasma determination of angiopoietin 2 4 hours after return to supine after the first PP session | Day 2 | Inflammation, pulmonary epithelial and endothelial dysfunction |
| Secondary | PaO2/FiO2 before each PP session | Up to Day 28 | Hematosis |
| Secondary | PaO2/FiO2 1 hour after PP initiation at each PP session | Up to Day 28 | Hematosis |
| Secondary | PaO2/FiO2 6 hours after PP initiation at each PP session | Up to Day 28 | Hematosis |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06212492/registered